Patents by Inventor Jan Ulmius

Jan Ulmius has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Method for the treatment of inflammatory bowel diseases
    Patent number: 6423340
    Abstract: Described herein are methods comprising the oral administration of budesonide for the treatment of ulcerative colitis and Crohn's colitis in its active phase. The methods can also be applied as relapse preventing therapy for Crohn's colitis in its chronic phase and Crohn's disease in the small intestine.
    Type: Grant
    Filed: September 23, 1998
    Date of Patent: July 23, 2002
    Assignee: Aktiebolaget Draco
    Inventor: Jan Ulmius
  • Oral composition for the treatment of inflammatory bowel disease
    Patent number: 5643602
    Abstract: An oral pharmaceutical composition is described for targeted slow release in the treatment of inflammatory bowel diseases. Also described are pharmaceutical compositions for peroral treatment targeted to different areas of the intestinal tract afflicted by ulcerative colitis and certain aspects of Crohn's disease.
    Type: Grant
    Filed: May 9, 1994
    Date of Patent: July 1, 1997
    Assignee: Astra Aktiebolag
    Inventor: Jan Ulmius
  • Pharmaceutical composition
    Patent number: 4363806
    Abstract: A pharmaceutical steroid composition for topical application producing a minimum of skin irritating effects. The composition comprises a corticosteroid in a multiple emulsion vehicle.A process for the preparation of the composition.
    Type: Grant
    Filed: June 12, 1981
    Date of Patent: December 14, 1982
    Assignee: Aktiebolaget Draco
    Inventors: Karl O. Bergstrom, Jan Ulmius, Bo L. T. Wenngren